Language

News topic

Start: 2025-04

All current shortage notices related to Start: 2025-04, structured by product, country, active ingredient and reporting period.

14 notices

← All shortages

Belgium

Sertraline Viatris 50 mg film-coat. tabl. 60

Active ingredient: Sertraline

View notice details →
Belgium

Hepacaf 5 000 IU inf. sol. (pwdr. + solv.) i.v. 5000 IU + 100 ml

Active ingredient: Human Hepatitis B Immunoglobulin

View notice details →
Austria

Venlafaxin Sandoz GmbH 225 mg – Hartkapseln, retardiert

Active ingredient: VENLAFAXIN HYDROCHLORID

View notice details →
Germany

Sertralin TAD 50 mg Filmtabletten

Active ingredient: Sertralinhydrochlorid

View notice details →
Germany

Sertralin TAD 100 mg Filmtabletten

Active ingredient: Sertralinhydrochlorid

View notice details →
Germany

Flupentixol-neuraxpharm 40 mg/ml

Active ingredient: Flupentixoldecanoat

View notice details →
Germany

Flupentixol-neuraxpharm 20 mg/ml

Active ingredient: Flupentixoldecanoat

View notice details →
Germany

Flupentixol-neuraxpharm 100 mg/ml

Active ingredient: Flupentixoldecanoat

View notice details →
Belgium

Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 5 x 100 mg

Active ingredient: Avalglucosidase Alfa

View notice details →
Austria

Quetialan XR 200 mg-Retardtabletten

Active ingredient: QUETIAPIN FUMARAT

View notice details →
Belgium

Colobreathe 1 662 500 IE (Abacus Medicine) inhalatiepdr. (harde caps.) 56

Active ingredient: Colistimethate Sodium

View notice details →
Austria

Aldactone 200 mg/ 10 ml Injektionslösung

Active ingredient: CANRENOINSÄURE

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.